LINDSAY A. MD ROSENWALD - 14 Nov 2023 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Role: President, CEO & Chairman, Director, 10%+ Owner
Signature: /s/ Samuel Berry, Attorney-in-Fact
Issuer symbol: FBIO
Transactions as of: 14 Nov 2023
Net transactions value: +$2,664,776
Form type: 4
Filing time: 16 Nov 2023, 17:50:28 UTC
Previous filing: 27 Sep 2023
Next filing: 03 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FBIO	COMMON STOCK, PAR VALUE $0.001	Purchase	$2,664,776	+1,567,515	+152%	$1.70	2,597,440	14 Nov 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FBIO	Warrants to purchase Common Stock	Purchase	$0	+1,567,515		$0.000000	1,567,515	14 Nov 2023	Common Stock	1,567,515	$1.70	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Effective October 10, 2023, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the "Reverse Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Split.
F2	The shares of common stock and warrants to purchase common stock reflect on this Form 4 were purchased as units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock, at a price per unit of $1.70.